Hexima Ltd
HXL
Company Profile
Business description
Hexima Ltd is a biotechnology company. The principal activity of the Group during the financial year was the exploration of transactions with third parties which could enable the potential value of the Company's assets, including its intellectual property, to be realized.
Contact
C/- Acclime, 62 Lygon Street
Level 3
CarltonVIC3053
AUST: +61 398245254
Sector
Financial Services
Stock type
Cyclical
Industry
Shell Companies
Fiscal Year End
30 June 2026
Employees
Stocks News & Analysis
stocks
Market Minute: RBA cuts rates again, US CPI data released
This week, the RBA cut rates after a surprise hold in July; CBA reported earnings ; US inflation data came out, showing its highest reading since February.
stocks
Is the market still overlooking Alibaba’s AI potential?
Despite a 40% share price rally this year, investors could still be underestimating Alibaba’s cloud growth prospects.
stocks
ASX reporting season wrap: CBA, JB Hi-Fi, REA and more
A round up of notable stories and reactions as ASX earnings season gathers steam.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,185.70 | 36.60 | 0.40% |
| CAC 40 | 7,870.34 | 65.37 | 0.84% |
| DAX 40 | 24,377.50 | 191.91 | 0.79% |
| Dow JONES (US) | 44,911.26 | 11.01 | -0.02% |
| FTSE 100 | 9,177.24 | 12.01 | 0.13% |
| HKSE | 25,215.10 | 304.22 | -1.19% |
| NASDAQ | 21,710.67 | 2.47 | -0.01% |
| Nikkei 225 | 43,166.22 | 516.96 | 1.21% |
| NZX 50 Index | 12,894.91 | 60.83 | 0.47% |
| S&P 500 | 6,468.54 | 1.96 | 0.03% |
| S&P/ASX 200 | 8,911.20 | 37.40 | 0.42% |
| SSE Composite Index | 3,683.58 | 17.14 | 0.47% |